Page 23 - 《中国药房》2024年10期
P. 23
参考文献 4829-4834.
[ 1 ] 蔡明远,张翠莲,周亮,等. 全国医疗机构制剂现状调研 [ 7 ] 王彦芳,陈娟娟,关克磊,等. 医院药师科研能力评价指
及问题分析[J]. 中国药房,2022,33(5):513-518. 标体系的构建及其信效度评价[J]. 中国药房,2023,34
CAI M Y,ZHANG C L,ZHOU L,et al. Nationwide (2):242-245.
investigation and problems analysis of pharmaceutical WANG Y F,CHEN J J,GUAN K L,et al. Construction of
preparations in medical institutions[J]. China Pharm, evaluation index system for scientific research ability of
2022,33(5):513-518. hospital pharmacists and analysis of its reliability and
[ 2 ] 王雅甜,李超,管志美. 医疗机构传统中药制剂备案管理 validity[J]. China Pharm,2023,34(2):242-245.
工作的分析与思考[J]. 中国药房,2022,33(3):263-270. [ 8 ] 唐密,杨燕,陈珉惺,等. 药品集中带量采购供应企业遴
WANG Y T,LI C,GUAN Z M. Analysis and reflection on 选多准则决策框架构建[J]. 中南药学,2023,21(8):
the filing management of traditional Chinese medicine 2219-2223.
preparations in medical institutions[J]. China Pharm, TANG M,YANG Y,CHEN M X,et al. Multi-criteria
2022,33(3):263-270. decision-making framework for the selection of drug sup‐
[ 3 ] 吴亚萍. 基于史密斯模型的医疗机构中药制剂备案管理 ply enterprises in centralized volume-based procurement
政策执行与对策[J]. 中医药管理杂志,2022,30(14): [J]. Cent South Pharm,2023,21(8):2219-2223.
141-143. [ 9 ] 江依帆,陈丽萍,张若钰,等. 抑酸药物的临床综合评价
WU Y P. Based on the Smith policy implementation 指标体系构建[J]. 中国药物评价,2023,40(5):416-421.
model of medical institutions of traditional Chinese medi‐ JIANG Y F,CHEN L P,ZHANG R Y,et al. Construction
cine preparation for the record management policies and of clinical comprehensive value evaluation system for
countermeasures research[J]. J Tradit Chin Med Manag, acid-inhibiting drugs[J]. Chin J Drug Eval,2023,40(5):
2022,30(14):141-143. 416-421.
[ 4 ] 罗李娜,陈更新. 医疗机构中药制剂开发模式[J]. 中华中 [10] 李波,王广建. 少弱精子症中西医结合诊疗河北专家共
医药杂志,2023,38(7):3224-3227. 识:2022版[J]. 河北中医,2022,44(9):1578-1584.
LUO L N,CHEN G X. Development mode of Chinese LI B,WANG G J. Hebei experts’ consensus on integrated
medicine in medical institutions[J]. China J Tradit Chin traditional Chinese and Western medicine for diagnosis
Med Pharm,2023,38(7):3224-3227. and treatment of oligoasthenozoospermia:2022 version
[ 5 ] 高敏洁. 人用经验在传统中药制剂备案中的应用情况研 [J]. Hebei J Tradit Chin Med,2022,44(9):1578-1584.
究[J]. 中国临床药学杂志,2022,31(5):359-364. [11] 牟娜,吴斌,邹任贤. 传统中药制剂备案中药学研究常见
GAO M J. Investigation on the application of human use 问题及对其向中药新药转化的影响分析[J]. 上海医药,
experience in filing traditional Chinese medicine prepara‐ 2023,44(13):12-15.
tions for record[J]. Chin J Clin Pharm,2022,31(5): MOU N,WU B,ZOU R X. Analysis of common pro-
359-364. blems in the research of traditional Chinese medicine
[ 6 ] 杨忠奇,高蕊,胡思源,等. 中药人用经验研究专家共识 preparations and the impact on their transformation into
[J]. 中国中药杂志,2022,47(18):4829-4834. new Chinese medicine[J]. Shanghai Med Pharm J,2023,
YANG Z Q,GAO R,HU S Y,et al. Expert consensus on 44(13):12-15.
human use experience research of traditional Chinese (收稿日期:2023-12-14 修回日期:2024-04-12)
medicine[J]. China J Chin Mater Med,2022,47(18): (编辑:孙 冰)
中国药房 2024年第35卷第10期 China Pharmacy 2024 Vol. 35 No. 10 · 1173 ·